User Experience With DuraTouch® in Patients With Type 1 or Type 2 Diabetes

Inclusion Criteria: * The decision to initiate treatment with DuraTouch® has been made by the participant/legally acceptable representative (LAR) and the treating physician before and independently from the decision to include the participant in this study. * All needed signed consent(s) are obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol). Exclusion Criteria: * Previous participation in this study. Participation is defined as having given informed consent in this study. * Mental incapacity (when no caregiver and LAR are assigned to the patient), unwillingness or language barriers precluding adequate understanding or cooperation.